Entry and submarket concentration: empirical evidence from the pharmaceutical industry
Journal title ECONOMIA E POLITICA INDUSTRIALE
Author/s Maria Letizia Giorgetti
Publishing Year 2012 Issue 2012/3
Language English Pages 25 P. 5-29 File size 197 KB
DOI 10.3280/POLI2012-003001
DOI is like a bar code for intellectual property: to have more infomation
click here
Below, you can see the article first page
If you want to buy this article in PDF format, you can do it, following the instructions to buy download credits
FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.
The paper investigates the decisions of companies to enter new submarkets, analyzing the relationship between submarket concentration and entry through the explanatory power of submarkets. The relationship is analyzed both at the aggregate level for all countries and both at the country-specific level using a pharmaceutical company dataset gathered in seven countries in the 1987-1998 period. A Bayesian panel probit model enables us to measure entry into a new submarket using the lagged dependent variable to incorporate potential state persistence. The results obtained at the submarket level indicate a negative correlation between concentration and entry by diversification, although previous literature at market level has indicated conflicting results for the same relationship.
Keywords: Entry, diversification, Bayesian inference, panel data, probit model, random effects
Jel codes: L11, L65, C11, C23, C25
Maria Letizia Giorgetti, Entry and submarket concentration: empirical evidence from the pharmaceutical industry in "ECONOMIA E POLITICA INDUSTRIALE " 3/2012, pp 5-29, DOI: 10.3280/POLI2012-003001